Objective To study liver pathology in chronic hepatitis B virus (HBV) carriers with normal liver function.
目的探讨肝功能正常的慢性肝炎病毒携带者的肝组织病理分级和分期。
Hepatitis B virus (causes hepatitis and chronic cases may lead to cancer of the liver).
乙型肝炎病毒(造成肝炎，慢性肝炎可导致肝癌)。
It is generally accepted that virus factors and host factors are both important in the exacerbation and severity of chronic hepatitis b.
慢性乙型肝炎是否发病及发病的严重程度与病毒因素和宿主因素的共同作用有关。
Objective To study the status and significance of hepatitis B virus core internal deletion (CID) mutants in chronic hepatitis B and hepatocellular carcinoma patients.
目的研究乙型肝炎（乙肝）病毒核心基因内缺失突变株（ C I D）在慢性乙肝及肝癌患者中存在的状态及意义。
Methods Disability adjusted life year (DALY) was used to measure BOD of patients with chronic hepatitis B, cirrhosis and liver cancer caused by hepatitis B virus.
方法采用失能调整寿命年指标测量慢性乙肝、肝硬化和肝癌病人的疾病负担。
Objectives To explore the characteristics of hepatitis B virus genotypes in the subjects with chronic HBV infection.
目的探讨福州地区慢性HBV感染者的HBV基因型分布特征及其与病程的可能相关性。
Most of the patients with chronic liver diseases were infected with hepatitis B virus (HBV).
慢性肝病患者绝大多数已被乙型肝炎病毒(HBV)感染。
Method: 60 patients with chronic hepatitis Virus B were randomly divided into two groups, 32 in treating group and 28 in control group.
研究方法：我们将60例慢性乙型肝炎患者随机分为2组，治疗组32例，对照组28例。
Conclusions the relatively high ALT level, low HBV DNA ration and early virus response are the major factors that affect the curative effect of lamivudine in treating chronic hepatitis B.
结论治疗前较高的ALT水平，较低的HBVDNA定量值及出现早期病毒学应答是影响拉米夫定治疗慢性乙型肝炎疗效的主要因素。
Objective:To explore the correlation between different syndrome types of TCM and serum cytokines and replication of Virus index in chronic hepatitis B(CHB).
目的：观察慢性乙型肝炎（慢乙肝）患者细胞因子及病毒指标与中医证型的关系。
Chronic hepatitis Virus B is a kind of infectious disease which is severely threatening human health.
慢性乙型肝炎是一种严重危害人类健康的传染病。
To investigate the relationship between TCM type of syndromes and replication of virus in patients with chronic Hepatitis B.
探讨慢性乙肝中医证型与病毒复制之间的关系。
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
B型肝炎病毒流行病学，疾病负担，治疗，以及目前和新出现的预防和控制措施。
That patients with chronic hepatitis B treatment in contact with, as input, without anti-hepatitis C virus antibody testing of blood or blood products infected with hepatitis C, it is easy.
推测慢性乙肝病患在接触治疗时，由于输入未经抗丙肝病毒抗体检测的血液或血制品，就容易感染上丙肝。
Hepatitis B virus (HBV) is a major cause of acute and chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in humans.
乙型肝炎病毒(HBV)是人类急慢性肝炎、肝硬化和肝细胞癌的主要病因。
Incidence of hepatitis B virus (HBV) infection is much higher in maintenance hemodialysis (HD) patients than that in healthy controls or other chronic kidney disease patients who do not need HD.
维持性血液透析(血透)患者乙型肝炎病毒(HBV)感染率明显高于健康人群和慢性肾脏病非透析患者。
Methods 24 patients with chronic or advanced schistosomiasis (experimental group) and 26 healthy volunteers (control group) all without hepatitis B virus infection were selected for the study.
方法随机筛选无乙肝病毒感染的慢性血吸虫病患者(实验组)24例，健康志愿者(对照组)26例。
Methods 24 patients with chronic or advanced schistosomiasis (experimental group) and 26 healthy volunteers (control group) all without hepatitis B virus infection were selected for the study.
方法随机筛选无乙肝病毒感染的慢性血吸虫病患者(实验组)24例，健康志愿者(对照组)26例。
应用推荐